Company registration number: 96442654
Right now, injectables account for 17% of Wests sales and are the main driver of its growth
Hernandez EP, Shimazaki K, Niihara H, Umemiya-Shirafuji R, Fujisaki K, Tanaka T
Recent research has demonstrated that caffeine can reduce the risk of death from cardiovascular disease
Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial
Furthermore, miR-1307 was found to be a reliable predictor of chemotherapy effectiveness in patients, providing valuable guidance for individualized treatment plans in clinical settings